Catalent
CTLT
#1572
Rank
NZ$18.32 B
Marketcap
$100.98
Share price
0.60%
Change (1 day)
70.65%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.57 Billion

According to Catalent's latest financial reports the company has NZ$0.57 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalent - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30NZ$0.46 B-46.6%
2022-06-30NZ$0.86 B-37.53%
2021-06-30NZ$1.38 B-6.7%
2020-06-30NZ$1.48 B188.56%
2019-06-30NZ$0.51 B-15.17%
2018-06-30NZ$0.60 B44.27%
2017-06-30NZ$0.41 B115.81%
2016-06-30NZ$0.19 B-12.06%
2015-06-30NZ$0.22 B160.95%
2014-06-30NZ$84.77 M-38.3%
2013-06-30NZ$0.13 B-20.67%
2012-06-30NZ$0.17 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.68 B 20.36%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.29 B-48.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.46 B 681.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$0.54 B-3.67%๐Ÿ‡บ๐Ÿ‡ธ USA